KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Leases (2016 - 2018)

Medpace Holdings' Capital Leases history spans 4 years, with the latest figure at $24.5 million for Q4 2018.

  • For Q4 2018, Capital Leases fell 7.96% year-over-year to $24.5 million; the TTM value through Dec 2018 reached $24.5 million, down 7.96%, while the annual FY2018 figure was $24.5 million, 7.96% down from the prior year.
  • Capital Leases reached $24.5 million in Q4 2018 per MEDP's latest filing, down from $25.0 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $30.3 million in Q4 2015 to a low of $24.5 million in Q4 2018.
  • Average Capital Leases over 4 years is $27.1 million, with a median of $27.1 million recorded in 2017.
  • Peak YoY movement for Capital Leases: fell 5.77% in 2016, then dropped 7.96% in 2018.
  • A 4-year view of Capital Leases shows it stood at $30.3 million in 2015, then fell by 5.77% to $28.5 million in 2016, then decreased by 6.75% to $26.6 million in 2017, then decreased by 7.96% to $24.5 million in 2018.
  • Per Business Quant, the three most recent readings for MEDP's Capital Leases are $24.5 million (Q4 2018), $25.0 million (Q3 2018), and $25.6 million (Q2 2018).